Primary treatment of chronic pulmonary aspergillosis with weekly liposomal amphotericin B: A case report from Uganda

Primary treatment of chronic pulmonary aspergillosis with weekly liposomal amphotericin B: A case report from Uganda

Chronic pulmonary aspergillosis (CPA) treatment in Africa remains unexplored. We present a 23-year-old Ugandan male, previously treated thrice for pulmonary tuberculosis, developing CPA. Imaging showed lung fibrosis, bronchiectasis, and a fungal ball. He received weekly 600mg (10mg/kg) of liposomal...

Full description

Saved in:
Bibliographic Details
Main Authors: Winnie Kibone, Felix Bongomin, David W. Denning, David B. Meya
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Medical Mycology Case Reports
Subjects:
Aspergilloma
Liposomal amphotericin B
Treatment outcome
Resource limited settings
Online Access:http://www.sciencedirect.com/science/article/pii/S221175392400040X
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Chronic pulmonary aspergillosis (CPA) treatment in Africa remains unexplored. We present a 23-year-old Ugandan male, previously treated thrice for pulmonary tuberculosis, developing CPA. Imaging showed lung fibrosis, bronchiectasis, and a fungal ball. He received weekly 600mg (10mg/kg) of liposomal amphotericin B for six weeks, leading to marked clinical improvement. Weekly liposomal amphotericin B may be a viable treatment option for CPA in resource-limited settings.
ISSN:2211-7539

Similar Items